Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00004179
Recruitment Status : Completed
First Posted : January 27, 2003
Last Update Posted : February 15, 2021
Sponsor:
Collaborators:
Lymphoma Trials Office
Stichting Hemato-Oncologie voor Volwassenen Nederland
Australasian Leukaemia and Lymphoma Group
NCIC Clinical Trials Group
Nordic Lymphoma Group
Information provided by (Responsible Party):
European Organisation for Research and Treatment of Cancer - EORTC

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : April 2004
Actual Study Completion Date : July 19, 2017
Publications of Results:
Other Publications: